New pharmacological strategies in vascular diseases: a novel intracellular calcium antagonist, HA1077 (AT-877) and cerebral vasospasm.
Asano
T
T
Department of Pharmaceutical Research Laboratories, Asahi Chemical Industry, Japan.
Hidaka
H
H
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives*; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors*; D004285:Dogs; D006168:Guinea Pigs; D007424:Intracellular Fluid / Q000378:metabolism; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D007546:Isoquinolines / Q000494:pharmacology*; D011817:Rabbits; D014652:Vascular Diseases / Q000188:drug therapy*
D007546:Isoquinolines; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C049347:fasudil; D002118:Calcium